Claim Details

View detailed information about this claim and its related sources.

Back to Claims

Claim Information

Complete details about this extracted claim.

Claim Text
In a statement provided to The Times on Monday, the company, which did not admit liability or fault in the settlement, noted that “no unopened, distributed Abbott infant formulas have ever tested positive” for the bacteria that sickened the babies, including containers from the homes of the infants.
Simplified Text
Abbott stated that no unopened, distributed infant formulas, including from the homes of sickened infants, have ever tested positive for the bacteria in question.
Confidence Score
1.000
Claim Maker
Abbott Laboratories
Context Type
News Article
Context Details
{
    "context": "Statement to The New York Times",
    "source_of_statement": "Abbott Laboratories"
}
Subject Tags
Health Business Safety
UUID
6466b906-3061-4418-b06d-37726f6ed653
Vector Index
✗ No vector
Created
September 18, 2026 at 2:01 AM (3 weeks ago)
Last Updated
September 18, 2026 at 2:01 AM (3 weeks ago)

Original Sources for this Claim (1)

All source submissions that originally contained this claim.

Screenshot of https://nytimes.com/2026/09/14/well/abbott-settlement-infant-formula.html
Abbott to Pay $385 Million to Settle Infant Formula Allegations
Completed News
12 claims 🔥
3 weeks ago
https://nytimes.com/2026/09/14/well/abbott-settlement-infant-formula.html

Abbott Laboratories will pay nearly $385 million to settle claims that it knowingly sold infant formula manufactured in facilities that did not meet safety requirements. This follows a 2022 recall linked to serious illnesses in babies and a nationwide formula shortage.

Infant Formula Abbott Laboratories Product Safety Recalls Justice Department Public Health

Similar Claims (5)

Other claims identified as semantically similar to this one.